A new Standard of Care in spinal muscular atrophy has been published.
TreatSMA has some exciting news to share about the new experimental drug being developed by Roche.
The Swiss Office for Social Security announced today that Spinraza will be funded across all types of spinal muscular atrophy in Switzerland.
Portuguese national health service has decided to offer Spinraza treatment.
The government of Macedonia has agreed to provide Spinraza treatment to all those with spinal muscular atrophy.
Hungary has agreed to provide Spinraza treatment to all children with SMA.